Myomo, Inc. Files Registration Statement for Proposed Follow-On Offering

CAMBRIDGE, Mass., November 13, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, announced the filing of a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed underwritten follow-on public offering of shares of its common stock and accompanying warrants to purchase common stock. Read more.